{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T14:13:34Z","timestamp":1793196814790,"version":"4.5.0"},"reference-count":39,"publisher":"Radcliffe Medical Media Ltd","license":[{"start":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T00:00:00Z","timestamp":1786492800000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/legalcode"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Card Fail Rev"],"abstract":"<jats:p>Background: Exercise intolerance in heart failure reflects heterogeneous mechanisms, including coronary microvascular dysfunction (CMD), obesity and sarcopenia. The aim of this study was to investigate the relationships between cardiopulmonary exercise capacity, coronary microvascular function and body composition in patients with suspected heart failure with preserved ejection fraction (HFpEF). Methods: In this single-centre cross-sectional study, consecutive patients presenting with chest discomfort or dyspnoea and an intermediate or high probability of HFpEF were enrolled. All patients underwent body composition analysis, adenosine stress echocardiography for coronary flow reserve (CFR) and cardiopulmonary exercise testing to assess peak oxygen consumption (VO2peak). Results: Of the 101 patients (mean age 63\u00a0years; 52.0% women), CMD (CFR &lt;2.5) was present in 40.6%. Mean VO2peak was 23.0\u00a0\u00b1\u00a05.3\u00a0ml\/min\/kg. Patients with lower VO2peak (&lt;23\u00a0ml\/min\/kg) had higher visceral fat area and percentage body fat. VO2peak correlated positively with CFR (r=0.344, p&lt;0.001) and septal e\u2032 velocity and inversely with E\/e\u2032. Skeletal muscle mass index correlated positively with VO2peak predominantly in obese patients (BMI \u226525\u00a0kg\/m2). In multivariable analysis, both CFR and degree of body fat remained independent correlates of VO2peak. Conclusion: In patients with suspected HFpEF, cardiopulmonary exercise capacity is closely associated with left ventricular diastolic function, coronary microvascular function and body composition. Preserved skeletal muscle mass may mitigate the adverse impact of obesity on exercise performance. These findings highlight the importance of integrated assessment of CMD and body composition and support targeted lifestyle and exercise interventions to improve functional capacity in HFpEF phenotypes.<\/jats:p>","DOI":"10.15420\/cfr.2026.16","type":"journal-article","created":{"date-parts":[[2026,8,8]],"date-time":"2026-08-08T14:03:42Z","timestamp":1786197822000},"source":"Crossref","is-referenced-by-count":1,"title":["Relationship of Cardiopulmonary Exercise Capacity to Coronary Microvascular Function and Body Composition in Patients with Suspected Heart Failure with Preserved Ejection Fraction"],"prefix":"10.15420","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3164-3258","authenticated-orcid":false,"given":"So Ree","family":"Kim","sequence":"first","affiliation":[{"id":[{"id":"https:\/\/ror.org\/04gjj3027","id-type":"ROR","asserted-by":"publisher"}],"name":"Korea University Anam Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8480-9082","authenticated-orcid":false,"given":"Dong-Hyuk","family":"Cho","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/04gjj3027","id-type":"ROR","asserted-by":"publisher"}],"name":"Korea University Anam Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6589-5122","authenticated-orcid":false,"given":"Mi-Na","family":"Kim","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/04gjj3027","id-type":"ROR","asserted-by":"publisher"}],"name":"Korea University Anam Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8299-1877","authenticated-orcid":false,"given":"Jung-Joon","family":"Cha","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/04gjj3027","id-type":"ROR","asserted-by":"publisher"}],"name":"Korea University Anam Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7788-7904","authenticated-orcid":false,"given":"Bo Ryun","family":"Kim","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/04gjj3027","id-type":"ROR","asserted-by":"publisher"}],"name":"Korea University Anam Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8138-1367","authenticated-orcid":false,"given":"Jeong Hoon","family":"Yang","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/04q78tk20","id-type":"ROR","asserted-by":"publisher"}],"name":"Sungkyunkwan University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6710-685X","authenticated-orcid":false,"given":"Seong-Mi","family":"Park","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/04gjj3027","id-type":"ROR","asserted-by":"publisher"}],"name":"Korea University Anam Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"6096","published-online":{"date-parts":[[2026,8,12]]},"reference":[{"key":"ref0","doi-asserted-by":"crossref","unstructured":"Kitzman DW, Little WC, Brubaker PH, et al. Pathophysiological characterization of isolated diastolic heart failure in comparison to systolic heart failure. JAMA 2002;288:2144\u201350. https:\/\/doi.org\/10.1001\/jama.288.17.2144; PMID:\u00a012413374.","DOI":"10.1001\/jama.288.17.2144"},{"key":"ref1","doi-asserted-by":"crossref","unstructured":"Verbrugge FH, Omote K, Reddy YNV, et al. Heart failure with preserved ejection fraction in patients with normal natriuretic peptide levels is associated with increased morbidity and mortality. Eur Heart J 2022;43:1941\u201351. https:\/\/doi.org\/10.1093\/eurheartj\/ehab911; PMID:\u00a035139159.","DOI":"10.1093\/eurheartj\/ehab911"},{"key":"ref2","doi-asserted-by":"crossref","unstructured":"Verwerft J, Soens L, Wynants J, et al. Heart failure with preserved ejection fraction: relevance of a dedicated dyspnoea clinic. Eur Heart J 2023;44:1544\u201356. https:\/\/doi.org\/10.1093\/eurheartj\/ehad141; PMID:\u00a036924194.","DOI":"10.1093\/eurheartj\/ehad141"},{"key":"ref3","doi-asserted-by":"crossref","unstructured":"Rahman H, Ryan M, Lumley M, et al. Coronary microvascular dysfunction is associated with myocardial ischemia and abnormal coronary perfusion during exercise. Circulation 2019;140:1805\u201316. https:\/\/doi.org\/10.1161\/circulationaha.119.041595; PMID:\u00a031707835.","DOI":"10.1161\/CIRCULATIONAHA.119.041595"},{"key":"ref4","doi-asserted-by":"crossref","unstructured":"Yang JH, Obokata M, Reddy YNV, et al. Endothelium-dependent and independent coronary microvascular dysfunction in patients with heart failure with preserved ejection fraction. Eur J Heart Fail 2020;22:432\u201341. https:\/\/doi.org\/10.1002\/ejhf.1671; PMID:\u00a031840366.","DOI":"10.1002\/ejhf.1671"},{"key":"ref5","doi-asserted-by":"crossref","unstructured":"Shah SJ, Lam CSP, Svedlund S, et al. Prevalence and correlates of coronary microvascular dysfunction in heart failure with preserved ejection fraction: PROMIS-HFpEF. Eur Heart J 2018;39:3439\u201350. https:\/\/doi.org\/10.1093\/eurheartj\/ehy531; PMID:\u00a030165580.","DOI":"10.1093\/eurheartj\/ehy531"},{"key":"ref6","unstructured":"Pepine CJ, Anderson RD, Sharaf BL, et al. Coronary microvascular reactivity to adenosine predicts adverse outcome in women evaluated for suspected ischemia: results from the National Heart, Lung and Blood Institute WISE (Women\u2019s Ischemia Syndrome Evaluation) study. J Am Coll Cardiol 2010;55:2825\u201332. https:\/\/doi.org\/10.1016\/j.jacc.2010.01.054; PMID:\u00a020579539."},{"key":"ref7","doi-asserted-by":"crossref","unstructured":"Taqueti VR, Solomon SD, Shah AM, et al. Coronary microvascular dysfunction and future risk of heart failure with preserved ejection fraction. Eur Heart J 2018;39:840\u20139. https:\/\/doi.org\/10.1093\/eurheartj\/ehx721; PMID:\u00a029293969.","DOI":"10.1093\/eurheartj\/ehx721"},{"key":"ref8","doi-asserted-by":"crossref","unstructured":"Park SM, Wei J, Cook-Wiens G, et al. Left ventricular concentric remodelling and functional impairment in women with ischaemia with no obstructive coronary artery disease and intermediate coronary flow reserve: a report from the WISE-CVD study. Eur Heart J Cardiovasc Imaging 2019;20:875\u201382. https:\/\/doi.org\/10.1093\/ehjci\/jez044; PMID:\u00a030904924.","DOI":"10.1093\/ehjci\/jez044"},{"key":"ref9","doi-asserted-by":"crossref","unstructured":"Haykowsky MJ, Brubaker PH, John JM, et al. Determinants of exercise intolerance in elderly heart failure patients with preserved ejection fraction. J Am Coll Cardiol 2011;58:265\u201374. https:\/\/doi.org\/10.1016\/j.jacc.2011.02.055; PMID:\u00a021737017.","DOI":"10.1016\/j.jacc.2011.02.055"},{"key":"ref10","doi-asserted-by":"crossref","unstructured":"Obokata M, Reddy YNV, Pislaru SV, et al. Evidence supporting the existence of a distinct obese phenotype of heart failure with preserved ejection fraction. Circulation 2017;136:6\u201319. https:\/\/doi.org\/10.1161\/circulationaha.116.026807; PMID:\u00a028381470.","DOI":"10.1161\/CIRCULATIONAHA.116.026807"},{"key":"ref11","doi-asserted-by":"crossref","unstructured":"Pandey A, Patel KV, Vaduganathan M, et al. Physical activity, fitness, and obesity in heart failure with preserved ejection\u00a0fraction. JACC Heart Fail 2018;6:975\u201382. https:\/\/doi.org\/10.1016\/j.jchf.2018.09.006; PMID:\u00a030497652.","DOI":"10.1016\/j.jchf.2018.09.006"},{"key":"ref12","doi-asserted-by":"crossref","unstructured":"Reddy YNV, Carter RE, Obokata M, et al. A simple, evidence-based approach to help guide diagnosis of heart failure with preserved ejection fraction. Circulation 2018;138:861\u201370. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.118.034646; PMID:\u00a029792299.","DOI":"10.1161\/CIRCULATIONAHA.118.034646"},{"key":"ref13","doi-asserted-by":"crossref","unstructured":"Pieske B, Tsch\u00f6pe C, de Boer RA, et al. How to diagnose heart failure with preserved ejection fraction: the HFA-PEFF diagnostic algorithm: a consensus recommendation from the Heart Failure Association (HFA) of the European Society of Cardiology (ESC). Eur Heart J 2019;40:3297\u2013317. https:\/\/doi.org\/10.1093\/eurheartj\/ehz641; PMID:\u00a031504452.","DOI":"10.1093\/eurheartj\/ehz641"},{"key":"ref14","doi-asserted-by":"crossref","unstructured":"J\u00fcrs A, Pedersen LR, Olsen RH, et al. Coronary microvascular function, insulin sensitivity and body composition in predicting exercise capacity in overweight patients with coronary artery disease. BMC Cardiovasc Disord 2015;15:159. https:\/\/doi.org\/10.1186\/s12872-015-0151-9; PMID:\u00a026613591.","DOI":"10.1186\/s12872-015-0151-9"},{"key":"ref15","doi-asserted-by":"crossref","unstructured":"Kim SR, Cho DH, Kim MN, Park SM. Rationale and study design of differences in cardiopulmonary exercise capacity according to coronary microvascular dysfunction and body composition in patients with suspected heart failure with preserved ejection fraction. Int J Heart Fail 2021;3:237\u201343. https:\/\/doi.org\/10.36628\/ijhf.2021.0029; PMID:\u00a036262558.","DOI":"10.36628\/ijhf.2021.0029"},{"key":"ref16","doi-asserted-by":"crossref","unstructured":"Kim SM, Shim WJ, Lim HE, et al. Assessment of coronary flow reserve with transthoracic Doppler echocardiography: comparison with intracoronary Doppler method. J Korean Med Sci 2000;15:139\u201345. https:\/\/doi.org\/10.3346\/jkms.2000.15.2.139; PMID:\u00a010803688.","DOI":"10.3346\/jkms.2000.15.2.139"},{"key":"ref17","doi-asserted-by":"crossref","unstructured":"Won CW. Diagnosis of sarcopenia in primary health care. J Korean Med Assoc 2020;63:633\u201341. https:\/\/doi.org\/10.5124\/jkma.2020.63.10.633.","DOI":"10.5124\/jkma.2020.63.10.633"},{"key":"ref18","unstructured":"World Health Organization Regional Office for the Western Pacific. The Asia-Pacific Perspective: Redefining Obesity and its Treatment. Sydney: Health Communications, 2000."},{"key":"ref19","doi-asserted-by":"crossref","unstructured":"Bl\u00fcher M. Metabolically healthy obesity. Endocr Rev 2020;41:bnaa004. https:\/\/doi.org\/10.1210\/endrev\/bnaa004; PMID:\u00a032128581.","DOI":"10.1210\/endrev\/bnaa004"},{"key":"ref20","unstructured":"Wasserman K. Principles of exercise testing and interpretation: including pathophysiology and clinical applications. 5th ed. Philadelphia, PA: Wolters Kluwer Health\/Lippincott Williams & Wilkins, 2012."},{"key":"ref21","doi-asserted-by":"crossref","unstructured":"Glaab T, Taube C. Practical guide to cardiopulmonary exercise testing in adults. Respir Res 2022;23:9. https:\/\/doi.org\/10.1186\/s12931-021-01895-6; PMID:\u00a035022059.","DOI":"10.1186\/s12931-021-01895-6"},{"key":"ref22","unstructured":"Ponikowski P, Voors AA, Anker SD, et al. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart J 2016;37:2129\u2013200. https:\/\/doi.org\/10.1093\/eurheartj\/ehw128; PMID:\u00a027206819."},{"key":"ref23","doi-asserted-by":"crossref","unstructured":"Obokata M, Reddy YNV, Borlaug BA. Diastolic dysfunction and heart failure with preserved ejection fraction: understanding mechanisms by using noninvasive methods. JACC Cardiovasc Imaging 2020;13:245\u201357. https:\/\/doi.org\/10.1016\/j.jcmg.2018.12.034; PMID:\u00a031202759.","DOI":"10.1016\/j.jcmg.2018.12.034"},{"key":"ref24","doi-asserted-by":"crossref","unstructured":"Houstis NE, Eisman AS, Pappagianopoulos PP, et al. Exercise intolerance in heart failure with preserved ejection fraction: diagnosing and ranking its causes using personalized O2 pathway analysis. Circulation 2018;137:148\u201361. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.117.029058; PMID:\u00a028993402.","DOI":"10.1161\/CIRCULATIONAHA.117.029058"},{"key":"ref25","doi-asserted-by":"crossref","unstructured":"Camici PG, Tsch\u00f6pe C, Di Carli MF, et al. Coronary microvascular dysfunction in hypertrophy and heart failure. Cardiovasc Res 2020;116:806\u201316. https:\/\/doi.org\/10.1093\/cvr\/cvaa023; PMID:\u00a031999329.","DOI":"10.1093\/cvr\/cvaa023"},{"key":"ref26","doi-asserted-by":"crossref","unstructured":"Ho JE, Lyass A, Lee DS, et al. Predictors of new-onset heart failure: differences in preserved versus reduced ejection fraction. Circ Heart Fail 2013;6:279\u201386. https:\/\/doi.org\/10.1161\/CIRCHEARTFAILURE.112.972828; PMID:\u00a023271790.","DOI":"10.1161\/CIRCHEARTFAILURE.112.972828"},{"key":"ref27","doi-asserted-by":"crossref","unstructured":"Neeland IJ, Gupta S, Ayers CR, et al. Relation of regional fat distribution to left ventricular structure and function. Circ Cardiovasc Imaging 2013;6:800\u20137. https:\/\/doi.org\/10.1161\/CIRCIMAGING.113.000532; PMID:\u00a023929898.","DOI":"10.1161\/CIRCIMAGING.113.000532"},{"key":"ref28","doi-asserted-by":"crossref","unstructured":"Dalos D, Mascherbauer J, Zotter-Tufaro C, et al. Functional status, pulmonary artery pressure, and clinical outcomes in heart failure with preserved ejection fraction. J Am Coll Cardiol 2016;68:189\u201399. https:\/\/doi.org\/10.1016\/j.jacc.2016.04.052; PMID:\u00a027386773.","DOI":"10.1016\/j.jacc.2016.04.052"},{"key":"ref29","doi-asserted-by":"crossref","unstructured":"Ying W, Sharma K, Yanek LR, et al. Visceral adiposity, muscle composition, and exercise tolerance in heart failure with preserved ejection fraction. ESC Heart Fail 2021;8:2535\u201345. https:\/\/doi.org\/10.1002\/ehf2.13382; PMID:\u00a033939300.","DOI":"10.1002\/ehf2.13382"},{"key":"ref30","doi-asserted-by":"crossref","unstructured":"Fantuzzi G. Adipose tissue, adipokines, and inflammation. J Allergy Clin Immunol 2005;115:911\u20139; quiz 20. https:\/\/doi.org\/10.1016\/j.jaci.2005.02.023; PMID:\u00a015867843.","DOI":"10.1016\/j.jaci.2005.02.023"},{"key":"ref31","doi-asserted-by":"crossref","unstructured":"Pandey A, Kitzman D, Reeves G. Frailty is intertwined with heart failure: mechanisms, prevalence, prognosis, assessment, and management. JACC Heart Fail 2019;7:1001\u201311. https:\/\/doi.org\/10.1016\/j.jchf.2019.10.005; PMID:\u00a031779921.","DOI":"10.1016\/j.jchf.2019.10.005"},{"key":"ref32","doi-asserted-by":"crossref","unstructured":"Haykowsky MJ, Kouba EJ, Brubaker PH, et al. Skeletal muscle composition and its relation to exercise intolerance in older patients with heart failure and preserved ejection fraction. Am J Cardiol 2014;113:1211\u20136. https:\/\/doi.org\/10.1016\/j.amjcard.2013.12.031; PMID:\u00a024507172.","DOI":"10.1016\/j.amjcard.2013.12.031"},{"key":"ref33","doi-asserted-by":"crossref","unstructured":"Scandalis L, Kitzman DW, Nicklas BJ, et al. Skeletal muscle mitochondrial respiration and exercise intolerance in patients with heart failure with preserved ejection fraction. JAMA Cardiol 2023;8:575\u201384. https:\/\/doi.org\/10.1001\/jamacardio.2023.0957; PMID:\u00a037163294.","DOI":"10.1001\/jamacardio.2023.0957"},{"key":"ref34","doi-asserted-by":"crossref","unstructured":"Prado CM, Batsis JA, Donini LM, et al. Sarcopenic obesity in older adults: a clinical overview. Nat Rev Endocrinol 2024;20:261\u201377. https:\/\/doi.org\/10.1038\/s41574-023-00943-z; PMID:\u00a038321142.","DOI":"10.1038\/s41574-023-00943-z"},{"key":"ref35","doi-asserted-by":"crossref","unstructured":"Ong P, Athanasiadis A, Sechtem U. Pharmacotherapy for coronary microvascular dysfunction. Eur Heart J Cardiovasc Pharmacother 2015;1:65\u201371. https:\/\/doi.org\/10.1093\/ehjcvp\/pvu020; PMID:\u00a027533969.","DOI":"10.1093\/ehjcvp\/pvu020"},{"key":"ref36","doi-asserted-by":"crossref","unstructured":"Peng L, Zeng T, Quan E, et al. Obesity phenotypes causally affect cardiac MRI structure and induced non-ischaemic cardiomyopathy. Card Fail Rev 2025;11:e10. https:\/\/doi.org\/10.15420\/cfr.2024.26; PMID:\u00a040395981.","DOI":"10.15420\/cfr.2024.26"},{"key":"ref37","unstructured":"Knuuti J, Wijns W, Saraste A, et al. 2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes. Eur Heart J 2020;41:407\u201377. https:\/\/doi.org\/10.1093\/eurheartj\/ehz425; PMID:\u00a031504439."},{"key":"ref38","doi-asserted-by":"crossref","unstructured":"Sicari R, Rigo F, Cortigiani L, et al. Additive prognostic value of coronary flow reserve in patients with chest pain syndrome and normal or near-normal coronary arteries. Am J Cardiol 2009;103:626\u201331. https:\/\/doi.org\/10.1016\/j.amjcard.2008.10.033; PMID:\u00a019231324.","DOI":"10.1016\/j.amjcard.2008.10.033"}],"container-title":["Cardiac Failure Review"],"original-title":[],"link":[{"URL":"https:\/\/www.cfrjournal.com\/articleindex\/cfr.2026.16","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,8]],"date-time":"2026-08-08T14:03:48Z","timestamp":1786197828000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cfrjournal.com\/articleindex\/cfr.2026.16"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,12]]},"references-count":39,"URL":"https:\/\/doi.org\/10.15420\/cfr.2026.16","relation":{},"ISSN":["2057-7540","2057-7559"],"issn-type":[{"value":"2057-7540","type":"print"},{"value":"2057-7559","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,12]]},"article-number":"e20"}}